Global Erectile Dysfunction Market

Global Erectile Dysfunction Market Size, Share, Growth Analysis, By Product(Viagra, Cialis) - Industry Forecast 2024-2031


Report ID: SQSG35I2033 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 39 | Figures: 73

Global Erectile Dysfunction Market Dynamics

Erectile Dysfunction Market Driver

  • Diabetes, obesity, and cardiovascular disease are on the rise due to the rise in the adoption of an unhealthy lifestyle, which in turn causes issues like ED as people age. Young people's current lifestyles are particularly stressful in many emerging nations, which has led to an increase in fast food and ready-to-eat food consumption as well as drinking and smoking. These variables are compromising general health and fitness, which in turn raises the risk of ED. Additionally, the number of ED patients increases along with the senior population growth, which continues to be a major driver of the worldwide erectile dysfunction medications market during the projection period.
  • Major and growing pharmaceutical brands have boosted their investments in developing nations like India, China, Africa, and important Middle Eastern nations during the past couple of years. This has had a huge impact on the cost of medicine as well as the availability and distribution of medicines within the nations, both of which are anticipated to be important. The global market for erectile dysfunction medications is also anticipated to grow dramatically as a result of increased advertising investments.
  • Increasing research and development activities by the market players to provide new treatments for erectile dysfunction is expected to drive the growth of the market.

Erectile Dysfunction Market Restraint

  • Drugs for erectile dysfunction are primarily sold in developed and emerging economies; but, low- and middle-income countries account for a smaller portion of their sales. This is primarily a result of people's lack of understanding of these types of treatments, their limited purchasing power, and their unwillingness to incorporate them into their daily lives. The slow growth of the market is partly attributed to the negative side effects of these medications, which include headache, upset stomach, flushing, nasal congestion, visual issues, dizziness, diarrhea, and rash.
  • Two significant market challenges are the increased production of generic erectile dysfunction medications and the rising accessibility of fake erectile dysfunction medications. Due to the lucrative marketing of counterfeit erectile dysfunction medications at noticeably lower prices than either patented or generic pharmaceuticals, consumers frequently opt for less expensive generic erectile dysfunction pills over more expensive blockbuster varieties.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Erectile Dysfunction Market size was valued at USD 2.3 billion in 2019 and is poised to grow from USD 2.49 billion in 2023 to USD 4.73 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

Key market participants in the erectile dysfunction (ED) drugs market are strengthening their market positions by implementing a variety of strategies, including mergers and acquisitions and research partnerships with other businesses, to introduce novel products and solidify their market positions globally. For instance, due to a production error, Sun Pharmaceutical Industries Ltd. announced the recall of their generic medicine Tadalafil in November 2021. A small gap in the availability of generic ED medications used to treat erectile dysfunction patients may result from this recall. 'Pfizer Inc.', 'Eli Lilly and Company', 'Bayer AG', 'VIVUS, Inc.', 'Dong-A ST Co. Ltd.', 'Meda Pharmaceuticals Inc.', 'S.K. Chemicals Co. Ltd.', 'Teva Pharmaceutical Industries Ltd.', 'Endo International plc', 'Futura Medical plc', 'Apricus Biosciences, Inc.', 'Medtronic plc', 'Coloplast Corp.', 'Boston Scientific Corporation', 'Zephyr Surgical Implants', 'Urologix, LLC', 'American Medical Systems, Inc.', 'Augusta Medical Systems, LLC', 'Pos-T-Vac Medical'

Diabetes, obesity, and cardiovascular disease are on the rise due to the rise in the adoption of an unhealthy lifestyle, which in turn causes issues like ED as people age. Young people's current lifestyles are particularly stressful in many emerging nations, which has led to an increase in fast food and ready-to-eat food consumption as well as drinking and smoking. These variables are compromising general health and fitness, which in turn raises the risk of ED. Additionally, the number of ED patients increases along with the senior population growth, which continues to be a major driver of the worldwide erectile dysfunction medications market during the projection period.

The medication sildenafil is used to treat erectile dysfunction. By boosting blood flow to the penis, it aids males in obtaining an erection. At least two-thirds of the men who took it said their erections got better. The drug sildenafil is used to treat pulmonary arterial hypertension and erectile dysfunction, among other conditions. It is marketed under the trade name Viagra among others. Its efficacy in treating female sexual dysfunction has not been shown. The most popular medication used as initial therapy for erectile dysfunction is sildenafil (Viagra). So, throughout the projection period, the segment is anticipated to grow due to the success of Viagra (sildenafil citrate) in the treatment of erectile dysfunction.

The erectile dysfunction industry is expected to be dominated by North America. The prevalence of erectile dysfunction, the well-developed healthcare system, and the accessibility of treatment tools are all factors in the supremacy.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Erectile Dysfunction Market

Product ID: SQSG35I2033

$5,300
BUY NOW GET FREE SAMPLE